Plain-English translation of NCT00064870 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →The Alzheimer's Disease Genetics Study is building a large genetic repository to help researchers identify which genes may be responsible for Alzheimer's disease and related dementias. Researchers will use your genetic samples and family health information to study patterns and causes of the disease. Your participation helps advance scientific understanding that may benefit future patients.
Currently, scientists do not fully understand what causes Alzheimer's disease. By studying families where multiple members have been diagnosed, researchers hope to identify genetic factors that play a role in the disease's development.
You likely qualify if…
You likely don't qualify if…
Your family will donate a biological sample, most commonly a blood sample, which will be stored and shared with qualified researchers studying Alzheimer's genetics. The study does not involve taking any medication or attending regular visits. Please note that individual genetic test results will not be shared back with you or your family, as samples are stored without personal identifying information to protect your privacy.
AI-generated summary from trial data · Oct 3, 2026 · Not medical advice
United States
Collaborators
National Institute on Aging (NIA)
Enrollment target
~10,000 participants
Started
June 2002
Primary completion
August 2031
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Study Coordinator
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.